Which Healthcare ETF Is the Better Buy: iShares’ Global IXJ or First Trust’s Biotech FBT?

iShares Global Healthcare ETF (IXJ) and First Trust NYSE Arca Biotechnology Index Fund (FBT) offer different approaches to healthcare investing. IXJ provides diversified global exposure across 109 holdings with a lower 0.38% expense ratio and 1.4% dividend yield, making it suitable for long-term investors. FBT concentrates on 30 biotech companies with higher volatility but delivered 43.8% returns over one year versus IXJ's 19.5%. For most investors, IXJ's lower costs and stability make it the better foundation, while FBT suits those with higher conviction in biotech's continued growth.